Put Options

11 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $23,990 - $27,200
-500 Reduced 3.25%
14,900 $808,000
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $1.27 Million - $1.52 Million
-26,200 Reduced 62.98%
15,400 $790,000
Q3 2023

Nov 14, 2023

BUY
$57.89 - $64.73 $2.41 Million - $2.69 Million
41,600 New
41,600 $2.41 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $493,056 - $583,848
-7,200 Reduced 33.03%
14,600 $1.05 Million
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $2,834 - $1.68 Million
21,800 New
21,800 $1.55 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $491,840 - $589,760
8,000 Added 36.04%
30,200 $2.21 Million
Q4 2021

May 03, 2022

SELL
$53.63 - $62.52 $12.5 Million - $14.6 Million
-233,300 Reduced 91.31%
22,200 $1.38 Million
Q1 2020

May 15, 2020

SELL
$46.4 - $67.43 $37 Million - $53.8 Million
-797,900 Reduced 75.75%
255,500 $14.2 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $43.3 Million - $56.5 Million
879,600 Added 506.1%
1,053,400 $67.1 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $2.25 Million - $2.66 Million
52,500 Added 43.28%
173,800 $8.74 Million
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $5.41 Million - $5.98 Million
121,300 New
121,300 $5.5 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $88.3B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.